Search results
BMO cuts Abbvie stock PT on lower revenue outlook for Vraylar, Humira concerns By Investing.com
Investing.com· 17 hours agoOn Monday, BMO (TSX:BMO) Capital Markets adjusted its outlook onAbbvie (NYSE:ABBV), a...
AbbVie Is 'Firing On All Cylinders,' But Its Stock Doesn't Show That
Investor's Business Daily· 3 days agoAbbVie Stock: Earnings, Sales Beat Expectations Overall, AbbVie brought in $12.31 billion in sales...
AbbVie Q1 Preview: Skyrizi and Rinvoq’s launches could help Q1 (NYSE:ABBV)
Seeking Alpha· 5 days agoAbbVie (ABBV) is set to report Q1 earnings results on April 26th. Analysts expect a profit of $2.26...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 4 days agoOnce the world’s biggest-selling drug, Humira lost exclusivity last year, and nine biosimilars hit...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 3 days agoThe good news is that Pfizer's new products and newly approved indications for existing products...
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
Investing.com· 4 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
AbbVie: Q1 Earnings Snapshot - WTOP News
WTOP Washington· 4 days agoNORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Friday reported first-quarter earnings of $1.37 billion. On a per-share basis, the North Chicago…
Jim Cramer's quick thoughts on 5 stocks: Chevron, Snap, Intel, AbbVie and Colgate
CNBC· 4 days agoChevron : The oil giant beat on quarterly earnings but missed on revenue. "Maybe this is a chance to...
Here’s why ImmunityBio (IBRX) stock price surged and what next | Invezz
Invezz· 7 days agoImmunityBio (NASDAQ: IBRX) stock price resumed its strong rally this week after the company achieved...
AbbVie (ABBV) to Release Quarterly Earnings on Friday
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, April 26th. Analysts expect the company to announce ...
